Background. Clostridium difficile infection (CDI) is a common cause of nosocomial diarrhea. It can result in severe complications and death, especially among immunocompromised hosts. We conducted a single-center, retrospective cohort study to characterize CDI in lung transplant (LT) recipients (R).
Methods. The transplant database was reviewed for all adult LT (including heart-LT) performed between 2002 to 2011. CDI was defined by the presence of diarrhea and a positive stool test for toxigenic Clostridium difficile (enzyme immunoassay [EIA] for C. difficile toxins A and B from 2002 to June 2007 followed by polymerase chain reaction (PCR) from July 2007 onwards), or colonoscopic or histopathologic findings of pseudomembranous colitis.
Results. Fifteen of 91 LTR developed at least one CDI episode, with a total of 19 CDI episodes. The cumulative incidence of CDI was 9%, 11% and 18% at 6 months, 1 and 3 years post-transplantation respectively. Median time to diagnosis of first CDI episode was 164 days (interquartile range: 75 to 562 days) after LT. 80% (12 of 15) of LTR who developed CDI had received induction immunosuppression with OKT-3 or thymoglobulin. All but one patient was receiving a gastric acid-suppressing agent at the time of CDI diagnosis. 71% (10 of 14) were on a proton-pump inhibitor, and 29% (4 of 14) were on a H2-receptor blocker. All were receiving chronic antibiotic prophylaxis: 15 (100%) were on trimethoprim-sulfamethoxazole for Pneumocystis jiroveci prophylaxis; 9 (60%) were on azithromycin for bronchiolitis obliterans syndrome prophylaxis. LTR who developed CDI had a higher hazard of mortality after diagnosis (HR: 3.73; 95% CI (1.82-7.66); p-value <0.01), and only 26% (4 of 15) of LTR were alive at the conclusion of the study.
Conclusion. CDI is associated with increased mortality in LTR. LTR have many risk factors that predispose them to development of CDI. Strategies to decrease the risk of CDI are needed to improve survival in this patient population.
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